Clinical Trial Update: Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI) [NA]

View source ↗

Summary

The clinical trial investigating FlowMet in the management of critical limb ischemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Snippet

Sponsor: The Cleveland Clinic | Conditions: Critical Limb Ischemia | NA | Status: WITHDRAWN